lysophosphatidic acid has been researched along with Reperfusion Injury in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, OZ; Chiricolo, A; Kiss, GK; Liu, X; Mellender, SJ; Weiss, HR | 1 |
| Chi, OZ; Chiricolo, A; Jacinto, E; Kiss, GK; Liu, X; Mellender, SJ; Patel, N; Weiss, HR | 1 |
| Chen, J; Gu, Y; Li, TT; Li, YY; Tang, J; Wan, Q; Wang, C; Xiong, J; Yu, Y; Zhang, J; Zhang, Z; Zhao, X | 1 |
| Gao, J; Li, P; Su, X; Yang, X; Zhang, D; Zhang, Y | 1 |
| Geng, H; Gilchrist, A; Lan, R; Saikumar, P; Singha, PK; Venkatachalam, MA; Violette, SM; Weinberg, JM; Weinreb, PH | 1 |
| Dhallu, MS; Malhotra, S; Mammis, A; Ocava, LC; Rosenbaum, DM; Rosenbaum, PS; Savitz, SI | 1 |
6 other study(ies) available for lysophosphatidic acid and Reperfusion Injury
| Article | Year |
|---|---|
Lysophosphatidic Acid Reduces Microregional Oxygen Supply/Consumption Balance after Cerebral Ischemia-Reperfusion.
Topics: Animals; Cell Death; Cerebral Cortex; Cerebral Veins; Cerebrovascular Circulation; Disease Models, Animal; Infarction, Middle Cerebral Artery; Lysophospholipids; Male; Microcirculation; Oxygen; Oxygen Consumption; Rats, Inbred F344; Reperfusion Injury | 2020 |
Lysophosphatidic acid increased infarct size in the early stage of cerebral ischemia-reperfusion with increased BBB permeability.
Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Cerebral Cortex; Disease Models, Animal; Infarction, Middle Cerebral Artery; Lysophospholipids; Male; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Inbred F344; Reperfusion; Reperfusion Injury; Ribosomal Protein S6 Kinases | 2020 |
Lysophosphatidic acid induces neuronal cell death via activation of asparagine endopeptidase in cerebral ischemia-reperfusion injury.
Topics: Animals; Brain Ischemia; Cell Death; Cysteine Endopeptidases; Enzyme Activation; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Lysophospholipids; Male; Neurons; PC12 Cells; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke; tau Proteins | 2018 |
Lysophosphatidic acid and lovastatin might protect kidney in renal I/R injury by downregulating MCP-1 in rat.
Topics: Animals; Chemokine CCL2; Down-Regulation; Kidney; Lovastatin; Lysophospholipids; Male; Rats; Rats, Wistar; Reperfusion Injury | 2011 |
Lysophosphatidic acid increases proximal tubule cell secretion of profibrotic cytokines PDGF-B and CTGF through LPA2- and Gαq-mediated Rho and αvβ6 integrin-dependent activation of TGF-β.
Topics: Animals; Antigens, Neoplasm; Cell Nucleus; Connective Tissue Growth Factor; Cytokines; Fibrosis; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Integrins; Kidney Tubules, Proximal; Lipids; Lysophospholipids; Male; Mice; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; Regeneration; Reperfusion Injury; rho GTP-Binding Proteins; RNA, Messenger; Signal Transduction; Smad2 Protein; Time Factors; Transforming Growth Factor beta | 2012 |
EDG receptors as a potential therapeutic target in retinal ischemia-reperfusion injury.
Topics: Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Intraocular Pressure; Lysophospholipids; Male; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; Receptors, Lysosphingolipid; Reperfusion Injury; Retinal Diseases; Signal Transduction; Treatment Outcome | 2006 |